AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

DNA Vaccination Places Tumors In Double Jeopardy.(Brief Article)

Vaccine Weekly

| September 12, 2001 | COPYRIGHT 2001 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

2001 SEP 12 - (NewsRx.com & NewsRx.net) --

The endoplasmic reticulum resident chaperone protein calreticulin plays a surprising variety of roles in cell regulation, some of which make it particularly appealing for antitumor vaccination.

This protein can be cleaved in vivo to form the potent antiangiostatic factor vasostatin. In addition, when expressed in antigen-presenting cells, calreticulin interacts with the peptide processing machinery to facilitate loading of associated peptides with the Class I MHC complex.

Building on recent evidence that presentation of tumor-associated peptides through calreticulin can promote tumoricidal immune responses, Wen-Fang Cheng, of the National Taiwan University Hospital, and colleagues there and at the Johns Hopkins Medical Institutions have engineered a fusion gene encoding a known viral tumor antigen, linked directly to the chaperone.

They report in the September 2001 Journal of Clinical Investigation that mice exposed subdermally to this DNA construct enjoy seemingly complete resistance to tumor cells that express the viral antigen. Conversely, a simple ...

Related articles from newspapers, magazines, journals, and more
Research from Johns Hopkins University in the area of influenza published.
Newspaper article from: Vaccine Weekly May 20, 2009 700+ words
...Daugherty and colleagues, Johns Hopkins University. The researchers...E.L. Daugherty, Johns Hopkins University, School...Care, Vaccination, Johns Hopkins University. This article was prepared by Vaccine Weekly editors from staff...
Research conducted at Johns Hopkins University, Medical Department has updated...
Newspaper article from: Vaccine Weekly September 9, 2009 700+ words
...Ndhlovu and colleagues, Johns Hopkins University, Medical...contact M. Oelke, Johns Hopkins University, School...Vaccines, Virology, Johns Hopkins University, Medical...article was prepared by Vaccine Weekly editors from staff...
New findings reported from Johns Hopkins University, Medical Department...
Newspaper article from: Vaccine Weekly October 14, 2009 700+ words
...Chang and colleagues, Johns Hopkins University, Medical...contact C.F. Hung, Johns Hopkins University, School...Women's Health, Johns Hopkins University, Medical...article was prepared by Vaccine Weekly editors from staff...
Research on life sciences published by scientists at Johns Hopkins University,...
Newspaper article from: Vaccine Weekly July 29, 2009 700+ words
...Grosso and colleagues, Johns Hopkins University, Medical...contact C.G. Drake, Johns Hopkins University, School...Treatment, Therapy, Johns Hopkins University, Medical...article was prepared by Vaccine Weekly editors from staff...
Johns Hopkins awarded $30 million to develop, introduce pneumococcal vaccine.
Newspaper article from: Vaccine Weekly March 5, 2003 700+ words
...NewsRx.net) -- The Johns Hopkins Bloomberg School of Public...Plan (ADIP) team at the Johns Hopkins Bloomberg School of Public...MD, MHS, dean of the Johns Hopkins Bloomberg School of Public...article was prepared by Vaccine Weekly editors from staff and other...
CEL-SCI to Conduct First Clinical Study of Investigational LEAPS-H1N1 Treatment...
Newspaper article from: Vaccine Weekly November 18, 2009 700+ words
...Professor of Medicine, Johns Hopkins School of Medicine...Diseases Division, Johns Hopkins Bayview Medical Center...diligently with our CRO and Johns Hopkins, and actively preparing...article was prepared by Vaccine Weekly editors from staff...
Johns Hopkins and Lucent Technologies to Develop Global Network for...
Press release article from: PR Newswire December 14, 1999 700+ words
...BALTIMORE, Dec. 14 /PRNewswire/ -- Johns Hopkins Medicine and Lucent Technologies...Under the agreement, Lucent and Johns Hopkins International L.L.C., (JHI...advance the international objectives of Johns Hopkins Medicine -- will jointly design a...
Johns Hopkins Metabolic Bone Center Introduced at Johns Hopkins Bayview Medical...
Newspaper article from: Obesity & Diabetes Week November 24, 2008 700+ words
Johns Hopkins Bayview Medical Center announced the creation of the Johns Hopkins Metabolic Bone Center, a multidisciplinary...the most common of which is osteoporosis. The Johns Hopkins Metabolic Bone Center brings together the latest...
For more facts and information, see all results

Source: HighBeam Research, DNA Vaccination Places Tumors In Double Jeopardy.(Brief Article)

©2009 Gale, a part of Cengage Learning. All rights reserved.
About us | FAQs | Contact us | Privacy policy | Terms and conditions
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA